EurekaMag.com logo
+ Site Statistics
References:
53,517,315
Abstracts:
29,339,501
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Regional, geographic, and racial/ethnic variation in glycemic control in a national sample of veterans with diabetes



Regional, geographic, and racial/ethnic variation in glycemic control in a national sample of veterans with diabetes



Diabetes Care 34(4): 938-943



We performed a retrospective analysis of a national cohort of veterans with diabetes to better understand regional, geographic, and racial/ethnic variation in diabetes control as measured by HbA(1c). A retrospective cohort study was conducted in a national cohort of 690,968 veterans with diabetes receiving prescriptions for insulin or oral hypoglycemic agents in 2002 that were followed over a 5-year period. The main outcome measures were HbA(1c) levels (as continuous and dichotomized at ≥8.0%). Relative to non-Hispanic whites (NHWs), HbA(1c) levels remained 0.25% higher in non-Hispanic blacks (NHBs), 0.31% higher in Hispanics, and 0.14% higher in individuals with other/unknown/missing racial/ethnic group after controlling for demographics, type of medication used, medication adherence, and comorbidities. Small but statistically significant geographic differences were also noted with HbA(1c) being lowest in the South and highest in the Mid-Atlantic. Rural/urban location of residence was not associated with HbA(1c) levels. For the dichotomous outcome poor control, results were similar with race/ethnic group being strongly associated with poor control (i.e., odds ratios of 1.33 [95% CI 1.31-1.35] and 1.57 [1.54-1.61] for NHBs and Hispanics vs. NHWs, respectively), geographic region being weakly associated with poor control, and rural/urban residence being negligibly associated with poor control. In a national longitudinal cohort of veterans with diabetes, we found racial/ethnic disparities in HbA(1c) levels and HbA(1c) control; however, these disparities were largely, but not completely, explained by adjustment for demographic characteristics, medication adherence, type of medication used to treat diabetes, and comorbidities.

(PDF same-day service: $19.90)

Accession: 055445291

Download citation: RISBibTeXText

PMID: 21335370

DOI: 10.2337/dc10-1504



Related references

Racial and ethnic disparities in the control of cardiovascular disease risk factors in Southwest American veterans with type 2 diabetes: the Diabetes Outcomes in Veterans Study. Bmc Health Services Research 6(): 58-58, 2006

Variation in quality of care indicators for diabetes in a national sample of veterans and non-veterans. Diabetes Technology & Therapeutics 12(10): 785-790, 2011

Racial and ethnic differences in glycemic control of adults with type 2 diabetes. Diabetes Care 22(3): 403-408, 1999

Racial/Ethnic Disparities in Diabetes Diagnosis and Glycemic Control Among Women of Reproductive Age. Journal of Women's Health, 2018

Variation in receipt of pharmacotherapy for alcohol use disorders across racial/ethnic groups: A national study in the U.S. Veterans Health Administration. Drug and Alcohol Dependence 178: 527-533, 2017

Racial and ethnic differences in longitudinal blood pressure control in veterans with type 2 diabetes mellitus. Journal of General Internal Medicine 26(11): 1278-1283, 2012

Blood pressure control in diabetes: temporal progress yet persistent racial disparities: national results from the REasons for Geographic And Racial Differences in Stroke (REGARDS) study. Diabetes Care 33(4): 798-803, 2010

Ethnic/racial determinants of glycemic markers in a UK sample. Acta Diabetologica 52(4): 687-692, 2015

Racial and ethnic group variations in service use in a national sample of Medicare home health care patients with type 2 diabetes mellitus. Journal of the American Geriatrics Society 59(6): 1123-1129, 2011

Geographic Variation in Antidiabetic Agent Adherence and Glycemic Control Among Patients with Type 2 Diabetes. Journal of Managed Care & Specialty Pharmacy 21(12): 1195-1202, 2016

Effect of intensive glycemic control on microalbuminuria in type 2 diabetes. Veterans Affairs Cooperative Study on Glycemic Control and Complications in Type 2 Diabetes Feasibility Trial Investigators. Diabetes Care 23(10): 1478-1485, 2000

Intensified blood glucose monitoring improves glycemic control in stable, insulin-treated veterans with type 2 diabetes: the Diabetes Outcomes in Veterans Study (DOVES). Diabetes Care 26(6): 1759-1763, 2003

Facility-level variation in diabetes and blood pressure control in patients with diabetes: Findings from the Veterans Affairs national database. Clinical Cardiology, 2017

Cardiovascular events and correlates in the Veterans Affairs Diabetes Feasibility Trial. Veterans Affairs Cooperative Study on Glycemic Control and Complications in Type II Diabetes. Archives of Internal Medicine 157(2): 181-188, 1997

Effect of Veterans Administration use on indicators of diabetes care in a national sample of veterans. Diabetes Technology & Therapeutics 12(6): 427-433, 2010